STAT+: Pharmalittle: Merck’s Covid-19 pill reduced hospitalizations in a study; Dems start scaling back drug-pricing plans
A Merck experimental antiviral pill reduced the chances that patients newly diagnosed with Covid-19 would be hospitalized by about 50%.
by Ed Silverman
Oct 01, 2021
1 minute
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured
You’re reading a preview, subscribe to read more.
Start your free 30 days